These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37542830)
21. Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo. Roger P; Auclair J; Drain P J Diabetes Complications; 1999; 13(2):62-7. PubMed ID: 10432168 [TBL] [Abstract][Full Text] [Related]
22. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. Rothman RB; Clark RD; Partilla JS; Baumann MH J Pharmacol Exp Ther; 2003 Jun; 305(3):1191-9. PubMed ID: 12649307 [TBL] [Abstract][Full Text] [Related]
23. Screening for benfluorex and its major urinary metabolites in routine doping controls. Thevis M; Sigmund G; Gougoulidis V; Beuck S; Schlörer N; Thomas A; Kwiatkowska D; Pokrywka A; Schänzer W Anal Bioanal Chem; 2011 Aug; 401(2):543-51. PubMed ID: 21116611 [TBL] [Abstract][Full Text] [Related]
24. [Inductive effects of N-(benzoyloxy-2-ethyl)norfenfluramine (benfluorex) on hepatic microsomal enzymes in rats]. Mounié J; Goudonnet H; Bereksi-Reguig K; Escousse A; Truchot R C R Seances Soc Biol Fil; 1983; 177(4):471-80. PubMed ID: 6232983 [TBL] [Abstract][Full Text] [Related]
25. Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry. Le Ven F; Tribouilloy C; Habib G; Gueffet JP; Maréchaux S; Eicher JC; Blanchard-Lemoine B; Rousseau J; Hénon P; Jobic Y; Etienne Y Eur J Echocardiogr; 2011 Apr; 12(4):265-71. PubMed ID: 21193484 [TBL] [Abstract][Full Text] [Related]
26. [Mechanisms of hypoglycemic action of benfluorex]. Vigili de Kreutzenberg S; Riccio A; Dorella M; Da Tos V; Del Prato S Presse Med; 1992 Sep; 21(28):1340-3. PubMed ID: 1438104 [TBL] [Abstract][Full Text] [Related]
30. Cumulative incidence of cardiac surgery associated with exposure to benfluorex: A retrospective analysis based on compensation claims data. Farrington P; Lellinger S Stat Med; 2024 Jun; 43(13):2641-2654. PubMed ID: 38693582 [TBL] [Abstract][Full Text] [Related]
31. Studies on the ethanol-induced changes in glycerolipid synthesis in rats and their partial reversal by N-(2-benzoyloxyethyl)norfenfluramine (benfluorex). Pritchard PH; Brindley DN J Pharm Pharmacol; 1977 Jun; 29(6):343-9. PubMed ID: 18570 [No Abstract] [Full Text] [Related]
37. Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18 to 34-week, open-label, extension period. Moulin P; André M; Alawi H; Dos Santos LC; Khalid AK; Koev D; Moore R; Serban V; Picandet B; Francillard M Diabetes Metab; 2009 Feb; 35(1):64-70. PubMed ID: 19150252 [TBL] [Abstract][Full Text] [Related]
39. Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brain. Erenburg N; Hamed R; Shaul C; Perucca E; Bialer M Epilepsia; 2023 Jun; 64(6):1673-1683. PubMed ID: 36995363 [TBL] [Abstract][Full Text] [Related]
40. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat. Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]